OpenAlex
PricingAboutJobs
Log inGet started
Work

Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer

HTML

Year: 2017
Type: article
Study designs: Systematic Review, Meta-Analysis
Source: CHEST Journal
DOI: 10.1016/j.chest.2017.04.177
Authors: Monica Khunger, Sagar Rakshit, Vinay Pasupuleti, Adrian V. Hernandez, Peter Mazzone, James Stevenson, Nathan A. Pennell, Vamsidhar Velcheti
Institutions: Cleveland Clinic, Case Western Reserve University, Hartford Hospital, Peruvian University of Applied Sciences, University of Connecticut
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: immune-related adverse events, pneumonitis, PD-1 inhibitors, PD-L1 inhibitors, non-small cell lung cancer, nivolumab, pembrolizumab, atezolizumab, durvalumab, avelumab, prior chemotherapy, immune checkpoint inhibitors, treatment-naive patients
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2745126191
FWCI: 25
Cites: 29
Cited by: 553
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms